Infliximab is equivalently suppressing oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
about
Infliximab is equivalently suppressing oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Infliximab is equivalently sup ...... nts with rheumatoid arthritis.
@en
Infliximab is equivalently sup ...... nts with rheumatoid arthritis.
@nl
type
label
Infliximab is equivalently sup ...... nts with rheumatoid arthritis.
@en
Infliximab is equivalently sup ...... nts with rheumatoid arthritis.
@nl
prefLabel
Infliximab is equivalently sup ...... nts with rheumatoid arthritis.
@en
Infliximab is equivalently sup ...... nts with rheumatoid arthritis.
@nl
P2860
P356
P1476
Infliximab is equivalently sup ...... nts with rheumatoid arthritis.
@en
P2093
Fumiharu Yamashita
Tomoya Hayashi
P2860
P304
P356
10.1111/1756-185X.12972
P577
2016-10-24T00:00:00Z